Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs ThredUp Inc (TDUP) Price & Performance

Nuwellis IncTrade
ThredUp IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs ThredUp Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while ThredUp Inc trades at $2.73 (market cap $350.00M). The key difference: ThredUp Inc is far larger — about 140× Nuwellis Inc's market cap. Which is the better fit depends on your goals.

NUWETDUP
Market Cap
$2.50M$350.00M
Sector
TechnologyConsumer Cyclical
52-Week High
$164.50$10.92
52-Week Low
$0.73$2.52
Enterprise Value
-$1.21M$348.18M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.

While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.

ThredUp Inc

ThredUp (TDUP) trades at $2.67, down 1.84% on the day, amid a bearish technical signal. The company reported a Q2 2026 GAAP loss of $0.05 per share, missing the expected $0.03 loss, and cut its full-year revenue outlook, citing promotional headwinds. Despite a high gross margin of 79.52%, the firm remains unprofitable with a net income margin of -6.65%. Recent news includes participation in investor conferences and the launch of a peer-to-peer marketplace, but also multiple law firm investigations into securities claims following the earnings miss.

The outlook is clouded by persistent losses and competitive pressures, though analyst consensus leans Buy (57% of 14 analysts). Key risks include execution on profitability, the sustainability of revenue growth, and potential legal overhangs. The stock's trajectory hinges on demonstrating a clear path to net income positivity amid a challenging retail environment.

Returns comparison

Trailing returns across standard periods

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About ThredUp Inc

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.

Read more on TDUP